Biogrip-T

Biogrip-T may be available in the countries listed below.

Ingredient matches for Biogrip-T

Paracetamol

Paracetamol is reported as an ingredient of Biogrip-T in the following countries:

• Argentina

International Drug Name Search

Meosicam

Meosicam may be available in the countries listed below.

Ingredient matches for Meosicam

Meloxicam

Meloxicam is reported as an ingredient of Meosicam in the following countries:

• Taiwan

International Drug Name Search

Optipect

Optipect may be available in the countries listed below.

Ingredient matches for Optipect

Codeine

Codeine monohydrate (a derivative of Codeine) is reported as an ingredient of Optipect in the following countries:

• Germany

International Drug Name Search

Levodopa

In the US, Levodopa (levodopa systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease, Periodic Limb Movement Disorder and Restless Legs Syndrome.

US matches:

• Levodopa


• Levodopa/Carbidopa

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N04BA01

CAS registry number (Chemical Abstracts Service)

0000059-92-7

Chemical Formula

C9-H11-N-O4

Molecular Weight

197

Therapeutic Categories

Treatment of Parkinson's disease

Dopamine agonist

Chemical Name

L-Tyrosine, 3-hydroxy-

Foreign Names

• Levodopum (Latin)
• Levodopa (German)
• Lévodopa (French)
• Levodopa (Spanish)

Generic Names

• Levodopa (OS: DCIT, USAN, BAN)
• Lévodopa (OS: DCF)
• L-Dopa (IS)
• RP 15208 (IS)
• SE 200 (IS)
• Levodopa (PH: BP 2010, JP XIV, Ph. Int. 4, USP 32, Ph. Eur. 6)
• Lévodopa (PH: Ph. Eur. 6)
• Levodopum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

• Antiparkin (Levodopa and Carbidopa)
  GAMA, Georgia



• Apo-Levocarb (Levodopa and Carbidopa)
  Apotex, Canada



• Belepar (Levodopa and Benserazide)
  Teva, Poland



• Carbidopa + Levodopa Teva (Levodopa and Carbidopa)
  Teva, Italy



• Carbidopa and Levodopa (Levodopa and Carbidopa)
  Actavis, United States; Apotex, United States; Elan, United States; Endo, United States; Ethex, United States; Global, United States; Impax, United States; KV Pharmaceutical, United States; Mylan, United States; Sandoz, United States; Sun, United States; Teva USA, United States; Torpharm, United States; UDL, United States



• Carbidopa and Levodopa (Levodopa and Levodopa)
  Impax, United States; Sun, United States



• Carbidopa Levodopa Belmac (Levodopa and Carbidopa)
  Belmac, Spain



• Carbidopa Levodopa Davur (Levodopa and Carbidopa)
  Davur, Spain



• Carbidopa Lévodopa Teva LP (Levodopa and Carbidopa)
  Teva Santé, France



• Carbidopa Lévodopa Teva (Levodopa and Carbidopa)
  Teva Santé, France



• Carbidopa/Levodopa Sandoz (Levodopa and Carbidopa monohydrate)
  Sandoz, Switzerland; Sandoz, Netherlands



• Carbidopa/Levodopa Teva (Levodopa and Carbidopa)
  Teva, Italy; Teva, Latvia



• Carbidopa/Levodopa (Levodopa and Carbidopa)
  Teva, Romania



• Carbilev (Levodopa and Carbidopa)
  Aspen Pharmacare, South Africa; Ranbaxy, United States



• Carcopa (Levodopa and Carbidopa)
  Kyowa Yakuhin, Japan



• Cardopar (Levodopa and Carbidopa)
  DHA, Singapore



• Carlevod (Levodopa and Carbidopa)
  LKM, Argentina



• Cinetol (Levodopa and Carbidopa)
  Abbott, Peru



• Co-Beneldopa (Levodopa and Benserazide)
  Teva Pharmaceuticals, United Kingdom



• Co-Dopa (Levodopa and Carbidopa)
  Unimed & Unihealth, Bangladesh



• Credanil (Levodopa and Carbidopa)
  Remedica, Cyprus; Remedica, Romania



• D-Dopa Plus (Levodopa and Carbidopa)
  Drug International, Bangladesh



• Dopa Merz (Levodopa and Benserazide hydrochloride)
  Merz, Latvia



• Dopacol (Levodopa and Carbidopa)
  Daito, Japan



• Dopadura B (Levodopa and Benserazid)
  Mylan dura, Germany



• Dopadura C (Levodopa and Carbidopa)
  Mylan dura, Germany



• Dopamar (Levodopa and carbidopa)
  Sandoz, Poland



• Doparl
  Kyowa Hakko Kirin, Japan



• Dopasol
  Daiichi Sankyo, Japan



• Dopaston
  Ohara Yakuhin, Japan



• Dopicar (Levodopa and Carbidopa)
  Teva, Israel



• Duellin (Levodopa and Carbidopa)
  Egis, Hungary; Egis, Russian Federation



• Duodopa (Levodopa and Carbidopa)
  Solvay, Austria; Solvay, Australia; Solvay, Belgium; Solvay, Bulgaria; Solvay, Germany; Solvay, Denmark; Solvay, Estonia; Solvay, Spain; Solvay, Finland; Solvay, France; Solvay, United Kingdom; Solvay, Greece; Solvay, Croatia (Hrvatska); Solvay, Hungary; Solvay, Ireland; Solvay, Italy; Solvay, Lithuania; Solvay, Latvia; Solvay, Malta; Solvay, Netherlands; Solvay, Norway; Solvay, Poland; Solvay, Sweden; Solvay, Slovenia; Solvay, Slovakia; Solvay Pharma, Switzerland; Torrent, Brazil



• EC Doparl (Levodopa and Benserazide)
  Kyowa Hakko Kirin, Japan



• Grifoparkin (Levodopa and Carbidopa)
  Medco, Peru



• Half Sinemet (Levodopa and Carbidopa monohydrate)
  Bristol-Myers Squibb, United Kingdom



• Hardal (Levodopa and Benserazide)
  Farmindustria, Peru



• Isicom (Levodopa and Carbidopa)
  Desitin, Czech Republic; Desitin, Germany; Desitin, Romania; Desitin Pharma, Slovakia



• Kardopal (Levodopa and Carbidopa monohydrate)
  Orion, Finland



• Kinson (Levodopa and Carbidopa monohydrate)
  Alphapharm, Australia



• Lebocar (Levodopa and Carbidopa)
  Rontag, Argentina



• Lecardop (Levodopa and Carbidopa monohydrate)
  Teva, Czech Republic; Teva, Slovakia



• Lecarge (Levodopa and Carbidopa)
  Klonal, Argentina; Medigroup, Peru



• Ledopsan (Levodopa and Carbidopa)
  Teva, Spain



• Leparson (Levodopa and Benserazide HCL)
  Dexa Medica, Indonesia



• Leprinton (Levodopa and Carbidopa)
  Tatsumi Kagaku, Japan



• Levobens-Teva (Levodopa and Benserazide)
  Teva, Germany



• Levobeta (Levodopa and Carbidopa)
  Betapharm, Germany



• Levo-C AL (Levodopa and Carbidopa)
  Aliud, Germany



• LevoCar retard (Levodopa and Carbidopa)
  Stada, Austria



• Levocar (Levodopa and Carbidopa)
  Sandoz, Sweden



• Levocarb-1A Pharma (Levodopa and Carbidopa)
  1A Pharma, Germany



• Levocarb-GRY (Levodopa and Carbidopa)
  Teva-Gry, Germany



• Levocarbin
  G&R, Peru



• Levocarb-Teva (Levodopa and Carbidopa)
  Pharmachemie, Bulgaria; Teva, Bulgaria; Teva, Germany



• Levocomp (Levodopa and Carbidopa)
  Hexal, Germany



• Levodopa Benserazide Teva (Levodopa and Benserazide)
  Teva, Slovakia



• Lévodopa Bensérazide Teva (Levodopa and Benserazide)
  Teva Santé, France



• Levodopa C. comp. AbZ (Levodopa and Carbidopa)
  AbZ, Germany



• Levodopa Carbidopa Betapharm (Levodopa and Carbidopa)
  Betapharm, Netherlands



• Levodopa Carbidopa CF (Levodopa and Carbidopa)
  Centrafarm, Netherlands



• Levodopa Carbidopa Hexal (Levodopa and Carbidopa)
  Hexal, Italy; Hexal, Netherlands



• Levodopa Carbidopa PC (Levodopa and Carbidopa)
  Pharmachemie, Netherlands



• Levodopa Carbidopa Ratiopharm (Levodopa and Carbidopa)
  ratiopharm, Netherlands



• Levodopa Carbidopa Sandoz (Levodopa and Carbidopa)
  Sandoz, Germany; Sandoz, Netherlands



• Levodopa Carbidopa Stada (Levodopa and Carbidopa)
  Stada, Netherlands



• Levodopa comp TAD (Levodopa and Carbidopa monohydrate)
  TAD, Germany



• Levodopa comp. B Stada (Levodopa and Benserazide)
  Stada, Germany



• Levodopa comp. C Stada (Levodopa and Carbidopa)
  Stada, Germany



• Levodopa comp.-CT (Levodopa and Carbidopa)
  CT Arzneimittel, Germany



• Levodopa RPh (Levodopa and Carbidopa monohydrate)
  Lach, Germany



• Levodopa/Benserazid CT (Levodopa and Benserazid)
  CT Arzneimittel, Germany



• Levodopa/Benserazid ratiopharm (Levodopa and Benserazid)
  Ratiopharm, Sweden



• Levodopa/Benserazid-ratiopharm (Levodopa and Benserazid)
  Ratiopharm, Germany



• Levodopa/Carbidopa CF (Levodopa and Carbidopa monohydrate)
  Centrafarm, Netherlands



• Levodopa/Carbidopa Cimex (Levodopa and Carbidopa)
  Acino, Switzerland



• Levodopa/Carbidopa PCH (Levodopa and Carbidopa monohydrate)
  Pharmachemie, Netherlands



• Levodopa/Carbidopa ratiopharm (Levodopa and Carbidopa)
  ratiopharm, Denmark; ratiopharm, Sweden



• Levodopa/Carbidopa STADA (Levodopa and Carbidopa)
  Stada, Germany; Stada, Netherlands



• Levodopa/Carbidopa (Levodopa and Carbidopa monohydrate)
  Betapharm, Netherlands; Hexal, Netherlands



• Levodopa
  Remedica, Cyprus



• Levodopa-Benserazide (Levodopa and Benserazide)
  Lafedar, Argentina



• Levodopa-Carbidopa (Levodopa and Carbidopa monohydrate)
  Labinco, Colombia



• Levodopa-ratiopharm comp. (Levodopa and Carbidopa)
  Ratiopharm, Germany



• Levodop-neuraxpharm (Levodopa and Carbidopa)
  Neuraxpharm, Germany



• Levohexal (Levodopa and Carbidopa monohydrate)
  Sandoz, Australia



• Levomed (Levodopa and Carbidopa monohydrate)
  Medochemie, Hong Kong; Medochemie, Malta



• Levomet (Levodopa and Carbidopa)
  Unison, Singapore



• Levopar (Levodopa and Benserazide)
  Hexal, Germany; Meprofarm, Indonesia; Teva, Israel



• Madopar Quick (Levodopa and Benserazide)
  Roche, Iceland



• Madopar Retard (Levodopa and Benserazide)
  Roche, Spain



• Madopar (Levodopa and Benserazide)
  Chugai, Japan; Dr. Fisher, Netherlands; Eurim, Austria; Euro, Netherlands; Galenika, Serbia; Medcor, Netherlands; Roche, Albania; Roche, Armenia; Roche, Argentina; Roche, Austria; Roche, Australia; Roche, Aruba; Roche, Azerbaijan; Roche, Bosnia & Herzegowina; Roche, Bulgaria; Roche, Bulgaria; Roche, Bahrain; Roche, Bolivia; Roche, Brazil; Roche, Belarus; Roche, Switzerland; Roche, Cote D'ivoire; Roche, Chile; Roche, China; Roche, Colombia; Roche, Cuba; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Dominican Republic; Roche, Spain; Roche, Ethiopia; Roche, Finland; Roche, United Kingdom; Roche, Georgia; Roche, Guinea; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Hungary; Roche, Indonesia; Roche, Ireland; Roche, Iran; Roche, Iceland; Roche, Italy; Roche, Jamaica; Roche, Cambodia; Roche, South Korea; Roche, Kazakhstan; Roche, Laos; Roche, Lebanon; Roche, Sri Lanka; Roche, Lithuania; Roche, Luxembourg; Roche, Latvia; Roche, Libya; Roche, Morocco; Roche, Moldova; Roche, Mauritania; Roche, Malta; Roche, Mauritius; Roche, Mexico; Roche, Malaysia; Roche, Netherlands; Roche, Norway; Roche, New Zealand; Roche, Oman; Roche, Peru; Roche, Philippines; Roche, Poland; Roche, Portugal; Roche, Paraguay; Roche, Romania; Roche, Serbia; Roche, Russian Federation; Roche, Saudi Arabia; Roche, Singapore; Roche, Slovenia; Roche, Slovakia; Roche, Senegal; Roche, Syria; Roche, Thailand; Roche, Turkmenistan; Roche, Turkey; Roche, Trinidad & Tobago; Roche, Taiwan; Roche, Uruguay; Roche, Uzbekistan; Roche, Venezuela; Roche, Vietnam; Roche, South Africa; Tchaikapharma, Bulgaria; Terapia, Romania



• Madopark (Levodopa and Benserazide)
  Roche, Sweden



• Menesit (Levodopa and Carbidopa)
  Banyu Seiyaku, Japan



• Modopar (Levodopa and Benserazide)
  Roche, France; Roche, Tunisia



• Nakom (Levodopa and Carbidopa)
  Lek, Bosnia & Herzegowina; Lek, Czech Republic; Lek, Estonia; Lek, Georgia; Lek, Croatia (Hrvatska); Lek, Lithuania; Lek, Latvia; Lek, Poland; Lek, Romania; Lek, Serbia; Lek, Russian Federation; Lek, Slovenia; Merck Sharp & Dohme, Slovenia; Sandoz, Slovakia



• Neodopasol (Levodopa and Benserazide)
  Daiichi Sankyo, Japan



• Neodopaston (Levodopa and Carbidopa)
  Daiichi Sankyo, Japan



• Nervocur (Levodopa and Carbidopa)
  Fabra, Argentina



• Parcopa (Levodopa and Carbidopa)
  Schwarz, United States



• Pardoz (Levodopa and Benserazide hydrochloride)
  Kalbe, Indonesia



• Parken (Levodopa and Carbidopa)
  Psipharma, Colombia



• Parkidopa (Levodopa and Carbidopa)
  Cristália, Brazil



• Parkinel (Levodopa and Carbidopa)
  Bagó, Argentina



• Parkiston (Levodopa and Carbidopa)
  Kobayashi Kako, Japan



• PK-Levo (Levodopa and Benserazide)
  Merz, Germany



• Prikap (Levodopa and Carbidopa)
  Elea, Argentina



• Prolopa (Levodopa and Benserazide)
  Roche, Belgium; Roche, Brazil; Roche, Canada; Roche, Chile; Roche, Luxembourg



• Restex (Levodopa and Benserazide)
  Roche, Austria; Roche, Germany



• Sindopa (Levodopa and Carbidopa)
  Pacific, New Zealand



• Sindrob (Levodopa and Carbidopa)
  Farvet, Peru



• Sinemet (Levodopa and Carbidopa)
  Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Spain; Bristol-Myers Squibb, France; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, United States; Eurim, Austria; M & H, Thailand; Merck, Brazil; Merck Sharp & Dhome, Oman; Merck Sharp & Dohme, Argentina; Merck Sharp & Dohme, Austria; Merck Sharp & Dohme, Australia; Merck Sharp & Dohme, Belgium; Merck Sharp & Dohme, Bulgaria; Merck Sharp & Dohme, Czech Republic; Merck Sharp & Dohme, Estonia; Merck Sharp & Dohme, Hong Kong; Merck Sharp & Dohme, Croatia (Hrvatska); Merck Sharp & Dohme, Hungary; Merck Sharp & Dohme, Iceland; Merck Sharp & Dohme, Sri Lanka; Merck Sharp & Dohme, Lithuania; Merck Sharp & Dohme, Luxembourg; Merck Sharp & Dohme, Latvia; Merck Sharp & Dohme, Malaysia; Merck Sharp & Dohme, Netherlands; Merck Sharp & Dohme, New Zealand; Merck Sharp & Dohme, Peru; Merck Sharp & Dohme, Philippines; Merck Sharp & Dohme, Poland; Merck Sharp & Dohme, Portugal; Merck Sharp & Dohme, Sweden; Merck Sharp & Dohme, Singapore; Merck Sharp & Dohme, Turkey; Merck Sharp & Dohme, Taiwan; Merck Sharp & Dohme, Venezuela; Merck Sharp & Dohme, South Africa; MSD, Switzerland; MSD, Denmark; MSD, Finland; MSD, Norway; Vianex / BIANEΞ, Greece



• Sinemet CR (Levodopa and Carbidopa)
  Merck Sharp & Dohme, Chile; Merck Sharp & Dohme, China; Merck Sharp & Dohme, Croatia (Hrvatska); Merck Sharp & Dohme, Israel; Merck Sharp & Dohme, Lithuania; Merck Sharp & Dohme, New Zealand; Merck Sharp & Dohme, Peru; Merck Sharp & Dohme, Romania; MSD, Switzerland



• Sinepar (Levodopa andCarbidopa)
  Tchaikapharma, Bulgaria



• Stalevo (Levodopa and Carbidopa, + Entacapone)
  Novartis, Brazil; Novartis, Switzerland; Novartis, Indonesia; Novartis, Netherlands; Novartis, Singapore; Novartis, Thailand; Novartis, Taiwan; Novartis, South Africa; Orion, Austria; Orion, Czech Republic; Orion, Germany; Orion, Denmark; Orion, United Kingdom; Orion, Norway; Orion, Oman; Orion, Sweden; Orion, United States



• Striaton (Levodopa and Carbidopa)
  Abbott, Germany



• Sulconar (Levodopa and Carbidopa)
  Carrion, Peru



• Syndopa (Levodopa and Carbidopa)
  Sun, Bangladesh; Sun, India; Sun, Sri Lanka; Sun, Myanmar; Sun, Russian Federation



• Teva Carbi-Levo (Levodopa and Carbidopa)
  Teva Pharmaceuticals, South Africa



• Tidomet (Levodopa and Carbidopa)
  Torrent, Georgia; Torrent, Russian Federation; Torrent, Singapore



• Zimox (Levodopa and Carbidopa)
  Faran, Romania

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Womastin

Womastin may be available in the countries listed below.

Ingredient matches for Womastin

Carboplatin

Carboplatin is reported as an ingredient of Womastin in the following countries:

• Myanmar

International Drug Name Search

Tramadol-Rotexmedica

Tramadol-Rotexmedica may be available in the countries listed below.

Ingredient matches for Tramadol-Rotexmedica

Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Tramadol-Rotexmedica in the following countries:

• Germany

International Drug Name Search

Zentavion

Zentavion may be available in the countries listed below.

Ingredient matches for Zentavion

Azithromycin

Azithromycin dihydrate (a derivative of Azithromycin) is reported as an ingredient of Zentavion in the following countries:

• Spain

International Drug Name Search

Pyrazinamid

Pyrazinamid may be available in the countries listed below.

Ingredient matches for Pyrazinamid

Pyrazinamide

Pyrazinamide is reported as an ingredient of Pyrazinamid in the following countries:

• Austria


• Bosnia & Herzegowina


• Georgia


• Hungary


• Lithuania


• Poland


• Slovenia

International Drug Name Search

Lovastatin AbZ

Lovastatin AbZ may be available in the countries listed below.

Ingredient matches for Lovastatin AbZ

Lovastatin

Lovastatin is reported as an ingredient of Lovastatin AbZ in the following countries:

• Germany

International Drug Name Search

Novotrim

Novotrim may be available in the countries listed below.

Ingredient matches for Novotrim

Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Novotrim in the following countries:

• Peru

Trimethoprim

Trimethoprim is reported as an ingredient of Novotrim in the following countries:

• Peru

International Drug Name Search

Bisacodyl ratiopharm

Bisacodyl ratiopharm may be available in the countries listed below.

Ingredient matches for Bisacodyl ratiopharm

Bisacodyl

Bisacodyl is reported as an ingredient of Bisacodyl ratiopharm in the following countries:

• Netherlands

International Drug Name Search

Aten

Aten may be available in the countries listed below.

Ingredient matches for Aten

Atenolol

Atenolol is reported as an ingredient of Aten in the following countries:

• India


• Sri Lanka

International Drug Name Search

Bagopril

Bagopril may be available in the countries listed below.

Ingredient matches for Bagopril

Enalapril

Enalapril is reported as an ingredient of Bagopril in the following countries:

• Russian Federation

International Drug Name Search

Vitamec D3

Vitamec D3 may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vitamec D3

Colecalciferol

Colecalciferol is reported as an ingredient of Vitamec D3 in the following countries:

• Australia

International Drug Name Search

RibaPak

Generic Name: ribavirin (oral) (rye ba VYE rin)

Brand Names: Copegus, Rebetol, RibaPak, Ribasphere, RibaTab

What is ribavirin?

Ribavirin is an antiviral medication.

Ribavirin must be used together with an interferon alfa product (such as Pegasys, PegIntron, Sylatron, or Intron A) to treat chronic hepatitis C.

Ribavirin may also be used for purposes not listed in this medication guide.

What is the most important information I should know about ribavirin?

Ribavirin is not effective when used alone to treat hepatitis C. It must be used together with an interferon alfa product (such as Pegasys, PegIntron, Sylatron, or Intron A) to treat chronic hepatitis C. You should not take ribavirin if you are allergic to it, or if you have severe liver disease, autoimmune hepatitis, a hemoglobin disorder (anemia, thalassemia, and others), if you are also taking didanosine (Videx), or if you are pregnant woman, or a man whose female sexual partner is pregnant. This medication can cause birth defects or death in an unborn baby. If you are a woman, do not take ribavirin if you are pregnant. If you are a man, do not take ribavirin if your female sexual partner is pregnant. An unborn baby could also be harmed if a man fathers the child while he is taking ribavirin.

Use at least two effective forms of birth control while either sexual partner is taking ribavirin, and for at least 6 months after treatment ends. Tell your doctor right away if a pregnancy occurs while either the mother or the father is taking ribavirin.

Ribavirin may decrease the number of red blood cells in your body. This is called anemia and it can be life-threatening in people who have heart disease or circulation problems. Your blood will need to be tested often. Your vision, liver function, and thyroid function may also need to be tested. Visit your doctor regularly. Call your doctor at once if you have pale or yellowed skin, dark colored urine, fever, confusion, chest pain, weakness, or trouble breathing.

What should I discuss with my healthcare provider before taking ribavirin?

You should not take ribavirin if you are allergic to it, or if you have:

• 
  

  severe liver disease (especially cirrhosis);

  
  


• 
  

  autoimmune hepatitis;

  
  


• 
  

  a hemoglobin disorder such as anemia, thalassemia (Mediterranean anemia), or sickle-cell anemia;

  
  


• 
  

  if you are also taking didanosine (Videx); or

  
  


• 
  

  if you are pregnant woman, or a man whose female sexual partner is pregnant.

  
  

To make sure you can safely take ribavirin, tell your doctor if you have any of these other conditions:

• kidney or liver disease (other than hepatitis C);


• 
  

  hepatitis B infection;

  
  


• 
  

  a blood cell disorder such as hemolytic anemia (a lack of red blood cells);

  
  


• 
  

  human immunodeficiency virus (HIV or AIDS);

  
  


• 
  

  diabetes;

  
  


• 
  

  a pancreas disorder;

  
  


• 
  

  sarcoidosis;

  
  


• 
  

  breathing problems;

  
  


• 
  

  a thyroid disorder;

  
  


• 
  

  new or worsening eye problems (such as retinopathy);

  
  


• 
  

  a history of heart disease, high blood pressure, or a heart attack;

  
  


• 
  

  a history of depression or suicide attempt;

  
  


• 
  

  a history of a liver, kidney, or other organ transplant; or

  
  


• 
  

  if you have ever received treatment for hepatitis C that did not work well.

  
  

This medication can cause birth defects or death in an unborn baby.

• 
  

  If you are a woman, do not take ribavirin if you are pregnant. You will need frequent pregnancy tests to make sure you are not pregnant while taking ribavirin.

  
  


• 
  

  If you are a man, do not take ribavirin if your female sexual partner is pregnant. An unborn baby could also be harmed if a man fathers the child while he is taking ribavirin. Your sexual partner will need frequent pregnancy tests to make sure she is not pregnant while you are taking ribavirin.

  
  


• 
  

  Use at least two effective forms of birth control while either sexual partner is taking ribavirin, and for at least 6 months after treatment ends.

  
  


• 
  

  Tell your doctor right away if a pregnancy occurs while either the mother or the father is taking ribavirin.

  
  

Your name may need to be listed on a ribavirin pregnancy registry if you become pregnant while you or your male sexual partner are taking this medication or during the 6 months after treatment ends. This is to track the outcome of the pregnancy and to evaluate any effects of ribavirin on the baby.

It is not known whether ribavirin passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are taking ribavirin. Ribavirin may affect growth in children.

How should I take ribavirin?

Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.

Ribavirin is not effective when used alone to treat hepatitis C. It must be used together with an interferon alfa product (such as Peg-Intron or Intron A) to treat chronic hepatitis C. Take this medicine with food.

Measure the liquid form of ribavirin with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.

Ribavirin may decrease the number of red blood cells in your body. This is called anemia and it can be life-threatening in people who have heart disease or circulation problems. Your blood will need to be tested often. Your vision, liver function, and thyroid function may also need to be tested. Visit your doctor regularly. Call your doctor at once if you have pale or yellowed skin, dark colored urine, fever, confusion, chest pain, shortness of breath, or weakness. These may be signs of serious anemia.

Use ribavirin regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.

Drink extra fluids while you are taking ribavirin to keep from getting dehydrated, especially during exercise or in hot weather.

Ribavirin can cause dry mouth, which could lead to tooth decay or gum disease. If you vomit while taking ribavirin, rinse your mouth out with water to prevent damage to your teeth or gums. Be sure to have regular dental exams while you are taking this medication.

Store ribavirin tablets and capsules at room temperature away from moisture, heat, and light. Store ribavirin liquid (oral solution) in the refrigerator. Do not allow it to freeze.

What happens if I miss a dose?

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. If you have not taken the medication for longer than 24 hours, call your doctor for instructions. Do not take extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. Overdose symptoms may include easy bruising or bleeding, urinating less than usual or not at all, chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, or a general ill feeling.

What should I avoid while taking ribavirin?

Treatment with ribavirin does not prevent spread of the hepatitis C virus to other people. Follow your doctor's instructions about how to prevent passing the disease to another person.

Avoid drinking alcohol. It may increase your risk of liver damage. Ribavirin may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert.

Ribavirin side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using ribavirin and call your doctor at once if you have a serious side effect such as:

• 
  

  problems with your vision;

  
  


• 
  

  fever, chills, body aches, flu symptoms;

  
  


• 
  

  severe pain in your upper stomach spreading to your back, nausea and vomiting, fast heart rate;

  
  


• 
  

  stabbing chest pain, wheezing, feeling short of breath;

  
  


• 
  

  severe depression, hallucinations, thoughts of suicide or hurting yourself;

  
  


• 
  

  chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling; or

  
  


• 
  

  pale or yellowed skin, dark colored urine, easy bruising or bleeding, confusion, or unusual weakness.

  
  

Less serious side effects may include:

• 
  

  headache;

  
  


• 
  

  muscle pain;

  
  


• 
  

  dry mouth;

  
  


• 
  

  nausea; vomiting, stomach pain, loss of appetite;

  
  


• 
  

  weight loss;

  
  


• 
  

  feeling tired or irritable;

  
  


• 
  

  anxiety, mood changes; or

  
  


• 
  

  pain, swelling, or irritation where the interferon injection was given.

  
  

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect ribavirin?

Tell your doctor about all other medicines you use, especially:

• 
  

  abacavir (Ziagen);

  
  


• 
  

  azathiopriine (Azasan, Imuran);

  
  


• 
  

  lamivudine (Combivir, Epivir, Epzicom, Trizivir);

  
  


• 
  

  stavudine (Zerit);

  
  


• 
  

  tenofovir (Viread);

  
  


• 
  

  zalcitabine (Hivid); or

  
  


• 
  

  zidovudine (Retrovir, AZT).

  
  

This list is not complete and other drugs may interact with ribavirin. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.

More RibaPak resources

• RibaPak Side Effects (in more detail)
• RibaPak Use in Pregnancy & Breastfeeding
• RibaPak Drug Interactions
• RibaPak Support Group
• 0 Reviews for RibaPak - Add your own review/rating

• RibaPak Advanced Consumer (Micromedex) - Includes Dosage Information


• Ribavirin Prescribing Information (FDA)


• Ribavirin Professional Patient Advice (Wolters Kluwer)


• Ribavirin Monograph (AHFS DI)


• Copegus MedFacts Consumer Leaflet (Wolters Kluwer)


• Copegus Prescribing Information (FDA)


• Rebetol Prescribing Information (FDA)


• Rebetol Consumer Overview


• Rebetol MedFacts Consumer Leaflet (Wolters Kluwer)


• Ribasphere Consumer Overview


• Ribasphere Prescribing Information (FDA)


• Virazole Prescribing Information (FDA)


• Virazole Advanced Consumer (Micromedex) - Includes Dosage Information


• Virazole Solution MedFacts Consumer Leaflet (Wolters Kluwer)

Compare RibaPak with other medications

• Hepatitis C

Where can I get more information?

• Your pharmacist can provide more information about ribavirin.

See also: RibaPak side effects (in more detail)

Emicipro

Emicipro may be available in the countries listed below.

Ingredient matches for Emicipro

Ciprofloxacin

Ciprofloxacin is reported as an ingredient of Emicipro in the following countries:

• Bahrain


• Oman

International Drug Name Search

Sparflox

Sparflox may be available in the countries listed below.

Ingredient matches for Sparflox

Sparfloxacin

Sparfloxacin is reported as an ingredient of Sparflox in the following countries:

• Bangladesh

International Drug Name Search

Budema

Budema may be available in the countries listed below.

Ingredient matches for Budema

Bumetanide

Bumetanide is reported as an ingredient of Budema in the following countries:

• Taiwan

International Drug Name Search

Alvolex

Alvolex may be available in the countries listed below.

Ingredient matches for Alvolex

Salbutamol

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Alvolex in the following countries:

• Bangladesh

International Drug Name Search

Oxaprozine

Oxaprozine may be available in the countries listed below.

Ingredient matches for Oxaprozine

Oxaprozin

Oxaprozine (DCF) is known as Oxaprozin in the US.

International Drug Name Search

Glossary

DCF	Dénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

CitaLich

CitaLich may be available in the countries listed below.

Ingredient matches for CitaLich

Citalopram

Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of CitaLich in the following countries:

• Germany

International Drug Name Search

Brevicon

In the US, Brevicon (ethinyl estradiol/norethindrone systemic) is a member of the following drug classes: contraceptives, sex hormone combinations and is used to treat Abnormal Uterine Bleeding, Acne, Birth Control, Endometriosis, Gonadotropin Inhibition, Menstrual Disorders and Polycystic Ovary Syndrome.

US matches:

• Brevicon

Ingredient matches for Brevicon

Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Brevicon in the following countries:

• Canada


• United States

Norethisterone

Norethisterone is reported as an ingredient of Brevicon in the following countries:

• Canada


• United States

International Drug Name Search

Trankilium

Trankilium may be available in the countries listed below.

Ingredient matches for Trankilium

Lorazepam

Lorazepam is reported as an ingredient of Trankilium in the following countries:

• Greece

International Drug Name Search

Depo-Estradiol

Pronunciation: ESS-truh-DIE-ole sip-EYE-oh-nate
Generic Name: Estradiol Cypionate
Brand Name: Depo-Estradiol

Estrogens have been reported to increase the chance of womb (endometrial) cancer in women who have been through menopause, especially in women who receive estrogen-only hormone therapy. Contact your doctor immediately if you experience any unusual vaginal bleeding. Estrogens may also increase the risk of cancer of the ovary or breast. Estrogen-containing products should not be used to prevent heart disease. Estrogen given with another hormone (progestin) for replacement therapy can infrequently cause heart disease (eg, heart attacks), stroke, serious blood clots in the legs or lungs (pulmonary embolism/deep vein thrombosis), dementia, and cancer of the breast. These risks appear to depend on the length of time Depo-Estradiol is used and the amount of estrogen per dose. Therefore, Depo-Estradiol should be used for the shortest possible length of time at the lowest effective dose so that you obtain the benefits and minimize the chance of serious side effects from long-term treatment. Consult your doctor or pharmacist for details.

Depo-Estradiol is used for:

Treating certain symptoms of menopause (eg, hot flashes, vaginal itching, burning, or dryness). It is used to treat low levels of estrogen caused by certain conditions. It may also be used for other conditions as determined by your doctor.

Depo-Estradiol is a female estrogen hormone. It works by replacing natural estrogens in a woman who can no longer produce enough estrogen.

Do NOT use Depo-Estradiol if:

• you are allergic to any ingredient in Depo-Estradiol


• you are pregnant or suspect you may be pregnant, or you have vaginal bleeding of abnormal or unknown cause


• you have known or suspected breast cancer or any other estrogen-dependent cancer


• you have any other estrogen-dependent cancer


• you have the blood disease porphyria, or a history of blood clots or liver problems


• you have had a recent (within the past year) stroke or heart attack

Contact your doctor or health care provider right away if any of these apply to you.

Before using Depo-Estradiol:

Some medical conditions may interact with Depo-Estradiol. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have breast lumps or disease, an abnormal mammogram, or a family history of breast cancer or blood clots


• if you have yellowing of the skin or whites of the eyes during pregnancy or with past estrogen use, or high blood pressure during pregnancy (toxemia)


• if you have a vaginal infection or womb problems (eg, uterine fibroids/endometriosis, abnormal vaginal bleeding, other uterine problems)


• if you have abnormal calcium levels in the blood, asthma, cancer, cholesterol or lipid problems, depression, diabetes, epilepsy, excessive weight gain, gallbladder disease, heart disease or other heart problems, high blood pressure, kidney or liver disease, low thyroid hormone levels, lupus, migraine headaches, pancreas disease, seizures, or yellowing of the skin or eyes


• if you smoke, are overweight, or will be having surgery


• if you have a history of alcohol or other substance abuse or dependence

Some MEDICINES MAY INTERACT with Depo-Estradiol. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Anticoagulants (eg, warfarin), corticosteroids (eg, prednisone), succinylcholine, or tacrine because their actions and side effects may be increased by Depo-Estradiol


• Anticoagulants (eg, warfarin) because their effectiveness may be decreased by Depo-Estradiol


• Barbiturates (eg, phenobarbital), hydantoins (eg, phenytoin), carbamazepine, rifampin, or St. John's wort because they may decrease Depo-Estradiol's effectiveness


• Azole antifungals (eg, ketoconazole) or macrolide antibiotics (eg, erythromycin) because they may increase the risk of Depo-Estradiol's side effects

This may not be a complete list of all interactions that may occur. Ask your health care provider if Depo-Estradiol may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Depo-Estradiol:

Use Depo-Estradiol as directed by your doctor. Check the label on the medicine for exact dosing instructions. Check the label on the medicine for exact dosing instructions.

• An extra patient leaflet is available with Depo-Estradiol. Talk to your pharmacist if you have questions about this information.


• Depo-Estradiol is usually given as an injection at your doctor's office, hospital, or clinic. If you will be using Depo-Estradiol at home, a health care provider will teach you how to use it. Be sure you understand how to use Depo-Estradiol. Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.


• Do not use Depo-Estradiol if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.


• Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.


• If you miss a dose of Depo-Estradiol, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Depo-Estradiol.

Important safety information:

• Depo-Estradiol may cause dizziness. This effect may be worse if you take it with alcohol or certain medicines. Use Depo-Estradiol with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Limit alcoholic beverages while you are using Depo-Estradiol.


• Depo-Estradiol may cause dark skin patches on your face (melasma). Exposure to the sun may make these patches darker and you may need to avoid prolonged sun exposure and sunlamps. Consult your doctor regarding the use of sunscreens and protective clothing.


• Depo-Estradiol may increase the risk of blood clots. The risk may be greater if you smoke (especially in women older than 35 years of age).


• Contact your health care provider if vaginal bleeding of unknown cause occurs. This could be a sign of a serious condition requiring immediate medical attention.


• Contact your health care provider if vaginal discomfort occurs or if you suspect you have developed an infection while taking Depo-Estradiol.


• Follow your doctor's instructions for examining your breasts, and report any lumps immediately.


• If you wear contact lenses and you develop problems with them, contact your doctor.


• If you will be having surgery or will be confined to a chair or bed for a long period of time (eg, a long plane flight), notify your doctor beforehand. Special precautions may need to be taken in these circumstances while you are taking Depo-Estradiol.


• Diabetes patients - Depo-Estradiol may affect your blood sugar. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.


• Depo-Estradiol may interfere with certain lab tests. Be sure your doctor and lab personnel know you are using Depo-Estradiol.


• Discuss with your doctor every 3 to 6 months whether treatment with Depo-Estradiol is still appropriate.


• Lab tests, including physical exams and blood pressure, may be performed while you use Depo-Estradiol. You should have breast and pelvic exams, and a Pap test at least once a year. You should also have periodic mammograms as determined by your doctor. Be sure to keep all doctor and lab appointments.


• Depo-Estradiol should not be used in CHILDREN; safety and effectiveness in children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: Do not use Depo-Estradiol if you are pregnant. Avoid becoming pregnant while you are taking it. If you think you may be pregnant, contact your doctor right away. Depo-Estradiol is found in breast milk. If you are or will be breast-feeding while you use Depo-Estradiol, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Depo-Estradiol:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Abnormal hair growth; breast tenderness; changes in sex drive; cramps; dizziness; flushing; hair loss; headache; lightheadedness; nausea; pain, swelling, or redness at the injection site; reduced tolerance to carbohydrates; stomach bloating and upset; swelling; vaginal infection; weight changes.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); abnormal vaginal bleeding; breast lumps; calf pain or tenderness; changes in vaginal bleeding (eg, spotting, breakthrough bleeding, prolonged bleeding); changes in vision or speech; chest pain; confusion; coughing of blood; mental/mood changes (eg, depression, memory loss); numbness of an arm or leg; one-sided weakness; pain, swelling, or tenderness in the stomach; problems with contact lenses (eg, changes in fit); severe headache, dizziness, fainting, or vomiting; sudden shortness of breath; swelling of hands or feet; unusual vaginal discharge, itching, or odor; weakness of an arm or leg; yellowing of the skin or eyes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Depo-Estradiol side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include excessive vaginal bleeding; severe nausea; vomiting.

Proper storage of Depo-Estradiol:

Depo-Estradiol is usually handled and stored by a health care provider. If you are using Depo-Estradiol at home, store Depo-Estradiol as directed by your pharmacist or health care provider. Keep Depo-Estradiol out of the reach of children and away from pets.

General information:

• If you have any questions about Depo-Estradiol, please talk with your doctor, pharmacist, or other health care provider.


• Depo-Estradiol is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Depo-Estradiol. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Depo-Estradiol resources

• Depo-Estradiol Side Effects (in more detail)
• Depo-Estradiol Use in Pregnancy & Breastfeeding
• Depo-Estradiol Drug Interactions
• Depo-Estradiol Support Group
• 0 Reviews for Depo-Estradiol - Add your own review/rating

• Depo-Estradiol Prescribing Information (FDA)


• Estradiol Professional Patient Advice (Wolters Kluwer)


• Estradiol Monograph (AHFS DI)


• estradiol Transdermal Advanced Consumer (Micromedex) - Includes Dosage Information


• Estradiol Prescribing Information (FDA)


• Alora Advanced Consumer (Micromedex) - Includes Dosage Information


• Alora Prescribing Information (FDA)


• Climara Consumer Overview


• Climara Prescribing Information (FDA)


• Delestrogen Prescribing Information (FDA)


• Estrace Prescribing Information (FDA)


• Estrace Advanced Consumer (Micromedex) - Includes Dosage Information


• Estrace Consumer Overview


• Estraderm Prescribing Information (FDA)


• Estradiol Patch Prescribing Information (FDA)


• Estrasorb Prescribing Information (FDA)


• Estrasorb Consumer Overview


• Evamist Consumer Overview


• Evamist Prescribing Information (FDA)


• Femring Prescribing Information (FDA)


• Femtrace Advanced Consumer (Micromedex) - Includes Dosage Information


• Femtrace Prescribing Information (FDA)


• Femtrace Consumer Overview


• Menostar Consumer Overview


• Menostar Prescribing Information (FDA)


• Vivelle Prescribing Information (FDA)


• Vivelle-Dot Prescribing Information (FDA)

Compare Depo-Estradiol with other medications

• Atrophic Urethritis
• Atrophic Vaginitis
• Hypoestrogenism
• Postmenopausal Symptoms

Calcium gluconicum Jacoby

Calcium gluconicum Jacoby may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Calcium gluconicum Jacoby

Calcium Gluconate

Calcium Gluconate is reported as an ingredient of Calcium gluconicum Jacoby in the following countries:

• Austria

Magnesium Chloride

Magnesium Chloride is reported as an ingredient of Calcium gluconicum Jacoby in the following countries:

• Austria

International Drug Name Search

Cardiazem

Cardiazem may be available in the countries listed below.

Ingredient matches for Cardiazem

Nitrendipine

Nitrendipine is reported as an ingredient of Cardiazem in the following countries:

• Chile

International Drug Name Search

Alairgix

Alairgix may be available in the countries listed below.

Ingredient matches for Alairgix

Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Alairgix in the following countries:

• France

International Drug Name Search

Deparex

Deparex may be available in the countries listed below.

Ingredient matches for Deparex

Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Deparex in the following countries:

• Greece

International Drug Name Search

Flucozole

Flucozole may be available in the countries listed below.

Ingredient matches for Flucozole

Fluconazole

Fluconazole is reported as an ingredient of Flucozole in the following countries:

• Thailand

International Drug Name Search

Lipo-Merz

Lipo-Merz may be available in the countries listed below.

Ingredient matches for Lipo-Merz

Etofibrate

Etofibrate is reported as an ingredient of Lipo-Merz in the following countries:

• Bahrain


• Cyprus


• Egypt


• Germany


• Hong Kong


• Jordan


• Kuwait


• Lebanon


• Luxembourg


• Malta


• Oman


• Portugal


• Saudi Arabia


• Sudan


• Taiwan


• United Arab Emirates


• Yemen

International Drug Name Search

Amlodipino Davur

Amlodipino Davur may be available in the countries listed below.

Ingredient matches for Amlodipino Davur

Amlodipine

Amlodipine mesilate (a derivative of Amlodipine) is reported as an ingredient of Amlodipino Davur in the following countries:

• Spain

International Drug Name Search

Neostigmin

Neostigmin may be available in the countries listed below.

Ingredient matches for Neostigmin

Neostigmine

Neostigmine metilsulfate (a derivative of Neostigmine) is reported as an ingredient of Neostigmin in the following countries:

• Croatia (Hrvatska)


• Sweden

International Drug Name Search

Medolexin

Medolexin may be available in the countries listed below.

Ingredient matches for Medolexin

Cefalexin

Cefalexin is reported as an ingredient of Medolexin in the following countries:

• Bahrain


• Cyprus


• Iraq


• Jordan


• Oman


• Sudan


• Yemen

Cefalexin monohydrate (a derivative of Cefalexin) is reported as an ingredient of Medolexin in the following countries:

• Hong Kong


• Malta

International Drug Name Search

Hexarinse

Hexarinse may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Hexarinse

Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Hexarinse in the following countries:

• Australia


• Germany

International Drug Name Search

Antigrippine Ibuprofen

Antigrippine Ibuprofen may be available in the countries listed below.

Ingredient matches for Antigrippine Ibuprofen

Ibuprofen

Ibuprofen is reported as an ingredient of Antigrippine Ibuprofen in the following countries:

• Netherlands

International Drug Name Search

Bisolvon Ampicilina

Bisolvon Ampicilina may be available in the countries listed below.

Ingredient matches for Bisolvon Ampicilina

Ampicillin

Ampicillin is reported as an ingredient of Bisolvon Ampicilina in the following countries:

• Peru

Bromhexine

Bromhexine is reported as an ingredient of Bisolvon Ampicilina in the following countries:

• Peru

International Drug Name Search

Metoclopramida Richmond

Metoclopramida Richmond may be available in the countries listed below.

Ingredient matches for Metoclopramida Richmond

Metoclopramide

Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Metoclopramida Richmond in the following countries:

• Argentina

International Drug Name Search

Bileco

Bileco may be available in the countries listed below.

Ingredient matches for Bileco

Bleomycin

Bleomycin is reported as an ingredient of Bileco in the following countries:

• Peru

Bleomycin sulfate (a derivative of Bleomycin) is reported as an ingredient of Bileco in the following countries:

• Argentina

International Drug Name Search

Denaze

Generic Name: chlorpheniramine, methscopolamine, and phenylephrine (KLOR fe NEER a meen, METH skoe POL a meen, FEN il EFF rin)

Brand Names: Aerohist Plus, Ah-Chew, Chlor-Mes, Dallergy (obsolete), Denaze, Duradryl, Durahist PE, DuraTan PE, Extendryl Chews, Histatab PH, Omnihist L.A., Ralix, Redur-PCM, Rescon MX

What is Denaze (chlorpheniramine, methscopolamine, and phenylephrine)?

Chlorpheniramine is an antihistamine that reduces the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.

Methscopolamine is an anticholinergic (an-tye-kol-in-URJ-ik) that has a drying effect on the nasal passages.

Phenylephrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).

The combination of chlorpheniramine, methscopolamine, and phenylephrine is used to treat runny nose, sneezing, itchy throat, watery eyes, and sinus congestion caused by allergies, the common cold, or the flu.

Chlorpheniramine, methscopolamine, and phenylephrine may also be used for other purposes not listed in this medication guide.

What is the most important information I should know about Denaze (chlorpheniramine, methscopolamine, and phenylephrine)?

Do not use this medicine if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days. Serious, life-threatening side effects can occur if you take cold or allergy medicine before the MAO inhibitor has cleared from your body.

Before using this medicine, tell your doctor if you have heart disease, high blood pressure, or a heart rhythm disorder, circulation problems, glaucoma, diabetes, a thyroid disorder, kidney disease, or problems with urination.

Do not use any other over-the-counter cold, cough, or allergy medication without first asking your doctor or pharmacist. If you take certain products together you may accidentally take too much of a certain drug. Read the label of any other medicine you are using to see if it contains chlorpheniramine or phenylephrine. Talk with your doctor if your symptoms do not improve after 5 days of treatment, or if you have a fever with a headache, cough, or skin rash.

What should I discuss with my health care provider before taking Denaze (chlorpheniramine, methscopolamine, and phenylephrine)?

Do not take this medication if you are allergic to chlorpheniramine, methscopolamine, phenylephrine, or to other cold or allergy medicines, diet pills, stimulants, or ADHD medications. Do not use this medicine if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days. Serious, life-threatening side effects can occur if you take a cold or allergy medicine before the MAO inhibitor has cleared from your body.

Before using this medication, tell your doctor if you are allergic to any drugs, or if you have:

• 
  

  heart disease, high blood pressure, or a heart rhythm disorder;

  
  


• 
  

  a blood vessel disorder or circulation problems;

  
  


• 
  

  glaucoma;

  
  


• 
  

  diabetes;

  
  


• 
  

  a thyroid disorder;

  
  


• 
  

  kidney disease;

  
  


• 
  

  asthma;

  
  


• 
  

  an enlarged prostate; or

  
  


• 
  

  problems with urination.

  
  

This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. This medication can decrease breast milk production, and also may pass into breast milk and could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Artificially-sweetened liquid forms of cold medicine may contain phenylalanine. This would be important to know if you have phenylketonuria (PKU). Check the ingredients and warnings on the medication label if you are concerned about phenylalanine.

How should I take Denaze (chlorpheniramine, methscopolamine, and phenylephrine)?

Take this medication exactly as it was prescribed for you. Do not take the medication in larger amounts, or take it for longer than recommended by your doctor. Follow the directions on your prescription label. Cold medicine is usually taken for only a short time until your symptoms clear up.

Take this medicine with a full glass of water. It is best to take this medicine with food.

Measure the liquid form of this medicine with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one. The suspension liquid form should be shaken well just before you measure a dose.

Do not crush, chew, break, or open an extended-release tablet unless your doctor tells you to. Swallow the pill whole. It is specially made to release medicine slowly in the body. Breaking or opening the pill would cause too much of the drug to be released at one time. However, some extended-release pills can be broken to split the dose. Ask your doctor or pharmacist if you have questions.

The chewable tablet must be chewed completely before you swallow it.

Tell your doctor if your symptoms do not improve after 5 days of treatment, or if you have a fever with a headache, cough, or skin rash.

This medication can cause you to have unusual results with allergy skin tests. Tell any doctor who treats you that you are taking an antihistamine.

Store this medicine at room temperature, away from heat, light, and moisture.

What happens if I miss a dose?

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at your next regularly scheduled time. Do not take extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention if you think you have used too much of this medicine. Overdose symptoms may include feeling restless or nervous, nausea, vomiting, extreme drowsiness, confusion, hallucinations, uneven heart rate, fainting, or seizure (convulsions).

What should I avoid while taking Denaze (chlorpheniramine, methscopolamine, and phenylephrine)?

This medication can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert.

Avoid becoming overheated or dehydrated during exercise and in hot weather.

Cold or allergy medicine, narcotic pain medicine, sleeping pills, muscle relaxers, and medicine for seizures, depression or anxiety can add to sleepiness caused by chlorpheniramine or methscopolamine. Tell your doctor if you need to use any of these other medicines.

Avoid taking diet pills, caffeine pills, or other stimulants (such as ADHD medications) without your doctor's advice.

Do not use any other over-the-counter cold, cough, or allergy medication without first asking your doctor or pharmacist. Chlorpheniramine and phenylephrine are contained in many medicines available over the counter. If you take certain products together you may accidentally take too much of a certain drug. Read the label of any other medicine you are using to see if it contains chlorpheniramine or phenylephrine. Avoid drinking alcohol. It can add to drowsiness caused by an antihistamine.

Denaze (chlorpheniramine, methscopolamine, and phenylephrine) side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have any of these serious side effects:

• 
  

  fast, pounding, or uneven heartbeat;

  
  


• 
  

  confusion, hallucinations, unusual thoughts or behavior;

  
  


• 
  

  severe dizziness, anxiety, restless feeling, or nervousness;

  
  


• 
  

  urinating less than usual or not at all;

  
  


• 
  

  easy bruising or bleeding, unusual weakness, fever, chills, body aches, flu symptoms;

  
  


• 
  

  increased blood pressure (severe headache, blurred vision, trouble concentrating, chest pain, numbness, seizure); or

  
  


• 
  

  nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).

  
  

Less serious side effects may include:

• 
  

  blurred vision;

  
  


• 
  

  dry mouth;

  
  


• 
  

  nausea, stomach pain, constipation;

  
  


• 
  

  mild loss of appetite;

  
  


• 
  

  dizziness, drowsiness, headache;

  
  


• 
  

  problems with memory or concentration;

  
  


• 
  

  ringing in your ears;

  
  


• 
  

  restlessness or excitability (especially in children);

  
  


• 
  

  warmth, tingling, or redness under your skin;

  
  


• 
  

  cold feeling in your hands or feet;

  
  


• 
  

  sleep problems (insomnia); or

  
  


• 
  

  skin rash or itching.

  
  

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Denaze (chlorpheniramine, methscopolamine, and phenylephrine)?

Before taking this medication, tell your doctor if you are using any other antihistamine or decongestant pills, liquids, or nasal sprays. Also tell your doctor if you are using any of the following drugs:

• 
  

  pramlintide (Symlin);

  
  


• 
  

  aspirin or salicylates (such as Disalcid, Doan's Pills, Dolobid, Salflex, Tricosal, and others);

  
  


• 
  

  an antidepressant such as amitriptyline (Elavil, Etrafon) or desipramine (Norpramin);

  
  


• 
  

  bladder or urinary medications such as oxybutynin (Ditropan, Oxytrol) or tolterodine (Detrol);

  
  


• 
  

  a diuretic (water pill), or medicines to treat high blood pressure, angina (chest pain), or other heart conditions;

  
  


• 
  

  medication to treat irritable bowel syndrome;

  
  


• 
  

  medicines to treat psychiatric disorders, such as chlorpromazine (Thorazine), risperidone (Risperdal), trazodone (Desyrel);

  
  


• 
  

  migraine headache medication such as sumatriptan (Imitrex), naratriptan (Amerge), zolmitriptan (Zomig), ergotamine (Ergostat, Ergomar); or

  
  


• 
  

  seizure medication such as carbamazepine (Carbatrol) or phenobarbital (Luminal, Solfoton).

  
  

This list is not complete and there may be other drugs that can interact with chlorpheniramine, methscopolamine, and phenylephrine. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.

More Denaze resources

• Denaze Side Effects (in more detail)
• Denaze Use in Pregnancy & Breastfeeding
• Denaze Drug Interactions
• Denaze Support Group
• 0 Reviews for Denaze - Add your own review/rating

• AH-Chew Chewable Tablets MedFacts Consumer Leaflet (Wolters Kluwer)


• Aerohist Plus Sustained-Release and Long-Acting Tablets MedFacts Consumer Leaflet (Wolters Kluwer)


• Allergy DN PE Prescribing Information (FDA)


• Dallergy Syrup Prescribing Information (FDA)


• Dehistine Prescribing Information (FDA)


• Duravent-DA Controlled-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)


• Rescon Prescribing Information (FDA)

Compare Denaze with other medications

• Nasal Congestion
• Rhinitis

Where can I get more information?

• Your pharmacist can provide more information about chlorpheniramine, methscopolamine, and phenylephrine.

See also: Denaze side effects (in more detail)

Diklofenak Sandoz

Diklofenak Sandoz may be available in the countries listed below.

Ingredient matches for Diklofenak Sandoz

Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diklofenak Sandoz in the following countries:

• Sweden

International Drug Name Search

Paroxetinhexal

Paroxetinhexal may be available in the countries listed below.

Ingredient matches for Paroxetinhexal

Paroxetine

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Paroxetinhexal in the following countries:

• Estonia

International Drug Name Search

Aakland Teat Spray

Aakland Teat Spray may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Aakland Teat Spray

Dodecylbenzene Sulfonic Acid

Dodecylbenzene Sulfonic Acid is reported as an ingredient of Aakland Teat Spray in the following countries:

• New Zealand

International Drug Name Search

Dolol Instant

Dolol Instant may be available in the countries listed below.

Ingredient matches for Dolol Instant

Paracetamol

Paracetamol is reported as an ingredient of Dolol Instant in the following countries:

• Belgium


• Luxembourg

International Drug Name Search

Bradol

Bradol may be available in the countries listed below.

Ingredient matches for Bradol

Metamizole

Metamizole sodium monohydrate (a derivative of Metamizole) is reported as an ingredient of Bradol in the following countries:

• Venezuela

Ulinastatin

Ulinastatin is reported as an ingredient of Bradol in the following countries:

• Japan

International Drug Name Search

Uropran

Uropran may be available in the countries listed below.

Ingredient matches for Uropran

Oxybutynin

Oxybutynin is reported as an ingredient of Uropran in the following countries:

• Colombia

International Drug Name Search

Biocilina

Biocilina may be available in the countries listed below.

Ingredient matches for Biocilina

Oxacillin

Oxacillin sodium (a derivative of Oxacillin) is reported as an ingredient of Biocilina in the following countries:

• Venezuela

International Drug Name Search

Risperidon ArrowGenerics

Risperidon ArrowGenerics may be available in the countries listed below.

Ingredient matches for Risperidon ArrowGenerics

Risperidone

Risperidone is reported as an ingredient of Risperidon ArrowGenerics in the following countries:

• Denmark


• Netherlands

International Drug Name Search

Cefepime Alvia

Cefepime Alvia may be available in the countries listed below.

Ingredient matches for Cefepime Alvia

Cefepime

Cefepime Hydrochloride (a derivative of Cefepime) is reported as an ingredient of Cefepime Alvia in the following countries:

• Greece

International Drug Name Search

Femvulen

Femvulen may be available in the countries listed below.

Ingredient matches for Femvulen

Algestone

Algestone 16α,17α-acetonide (a derivative of Algestone) is reported as an ingredient of Femvulen in the following countries:

• Colombia

Estradiol

Estradiol 17ß-enantate (a derivative of Estradiol) is reported as an ingredient of Femvulen in the following countries:

• Colombia

International Drug Name Search

Clémastine

Clémastine may be available in the countries listed below.

Ingredient matches for Clémastine

Clemastine

Clémastine (DCF) is known as Clemastine in the US.

International Drug Name Search

Glossary

DCF	Dénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Antiplak

Antiplak may be available in the countries listed below.

Ingredient matches for Antiplak

Ticlopidine

Ticlopidine hydrochloride (a derivative of Ticlopidine) is reported as an ingredient of Antiplak in the following countries:

• Dominican Republic

International Drug Name Search